Protein Expression and Purification Service

Obtaining a protein that is soluble, active, and pure enough is the first step in most experiments, and it is often the step that decides whether everything downstream works. No single expression host handles every target well: a small cytosolic enzyme, a disulfide-rich receptor fragment, a membrane protein, and a toxic kinase each place different demands on the cell that makes them. A protein expression and purification service begins by matching the target to the host most likely to yield it in a usable form, then shapes the construct and the purification around that choice.

The service spans the whole chain — sequence review and construct design, small-scale test expression, scale-up, purification, and characterization. A project can therefore be handed over at any stage, whether that is a bare amino-acid sequence or an existing construct that simply needs a better yield.

Choosing an Expression System

The host is selected on the protein's size, folding requirements, need for post-translational modification, and intended use. Each system has a distinct profile, and the choice is usually a trade-off between yield, fidelity, speed, and cost.

  • Bacterial systems. Bacterial hosts are fast, economical, and capable of high yields, which makes them the default for proteins that do not require eukaryotic processing. Within this group, some hosts are better suited to intracellular accumulation while others secrete the product into the culture medium, simplifying recovery and avoiding endotoxin contamination in the final sample.
  • Yeast systems. Yeast combines microbial growth with a eukaryotic folding and secretion pathway, so it suits proteins that need some processing but do not justify the cost of mammalian culture. It scales readily and is a common choice for secreted enzymes and antigens.
  • Insect cells with a baculovirus vector. This route supports larger and more complex proteins, multi-subunit assemblies, and many eukaryotic modifications. It is widely used when a bacterial or yeast host produces an inactive product.
  • Mammalian cells. Mammalian hosts provide the closest match to native folding, glycosylation, and assembly for proteins destined for functional or therapeutic research. They are slower and more expensive, but for some targets they are the only route that gives a correctly processed protein.
  • Cell-free systems. Protein is synthesized in vitro from a supplied template using the translation machinery of a cell extract, without maintaining living cells. This opens the door to proteins that are toxic to a host and to rapid, small-scale expression where speed matters more than volume.

Where a target falls outside the usual pattern — many disulfide bonds, a membrane-spanning region, toxicity to the host, or a need for a very high-purity single product — a specialized format is used rather than forcing the standard route. The dedicated services below cover those cases.

Our Expression Services

How a Project Runs

A project starts with the target sequence and the intended application, from which the host and construct strategy are chosen. Sequence review and codon adaptation come first, followed by construct design and small-scale test expression across one or more conditions. The condition giving the best balance of solubility and yield is then scaled up, the protein is purified by an appropriate capture and polishing sequence, and the final material is characterized before release. Throughout, the plan can be adjusted if the first round shows that the target needs a different host or a different folding strategy.

Applications

Expressed proteins support structural studies, enzyme and activity assays, antibody and reagent production, antigen preparation, and interaction or modification analyses. They are also produced as reference materials and controls for assay development, where batch-to-batch consistency matters as much as purity.

Quality and Deliverables

Each batch is characterized so the delivered protein is defined rather than assumed: identity and purity are confirmed, yield and solubility are reported, and activity or binding is checked where an assay exists. Deliverables include the protein at the agreed quantity and concentration together with a technical report describing the construct, the expression conditions, the purification sequence, and the characterization data. Batches that do not meet the agreed criteria are not released.

The service is for research only, not for clinical use.
0
Inquiry Basket